Aberrant promoter methylation of multiple genes is associated with various diseases, including Alzheimer's disease (AD). The goal of the present study was to determine whether dopamine receptor D4 (DRD4) promoter methylation is associated with AD. In the current study, the methylation levels of the DRD4 promoter were measured in 46 AD patients and 61 controls using bisulfite pyrosequencing technology. The results of the present study demonstrated that DRD4 promoter methylation was significantly higher in AD patients than in controls. A further breakdown analysis by gender revealed that there was a significant association of DRD4 promoter methylation with AD in males (23 patients and 45 controls). In conclusion, the results of the present study demonstrated that elevated DRD4 promoter methylation was associated with AD risk in males.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3892/mmr.2016.5560 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Disease modifying osteoarthritis drug discovery using a temporal phenotypic reporter in 3D aggregates of primary human chondrocytes.
J Orthop Res
December 2024
Biionix Cluster, Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA.
Article Synopsis
- The research focused on discovering new drugs that can modify osteoarthritis (OA) by boosting type II collagen production in chondrocytes using a novel, less destructive method.
- Primary human chondrocytes were engineered to express a reporter gene and cultured in 3D models to screen a library of natural compounds over three weeks.
- Aromoline, a bisbenzylisoquinoline alkaloid, showed promise in enhancing type II collagen expression, with dopamine receptor D4 (DRD4) identified as a potential target for future OA treatments.
Coordination among frequent genetic variants imparts substance use susceptibility and pathogenesis.
Front Neurosci
April 2024
Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.
Determining the key genetic variants is a crucial step to comprehensively understand substance use disorders (SUDs). In this study, utilizing whole exome sequences of five multi-generational pedigrees with SUDs, we used an integrative omics-based approach to uncover candidate genetic variants that impart susceptibility to SUDs and influence addition traits. We identified several SNPs and rare, protein-function altering variants in genes, , , and ; compound heterozygous variants in , , and , that play a significant role in the neurotransmitter-neuropeptide axis, specifically in the dopaminergic circuits.
View Article and Find Full Text PDFA preliminary study on the association of single nucleotide polymorphisms and methylation of dopamine system-related genes with psychotic symptoms in patients with methamphetamine use disorder.
Eur J Neurosci
April 2024
Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
Methamphetamine use disorder (MAUD) can substantially jeopardize public security due to its high-risk social psychology and behaviour. Given that the dopamine reward system is intimately correlated with MAUD, we investigated the association of single nucleotide polymorphisms (SNPs), as well as methylation status of dopamine receptor type 4 (DRD4), catechol-O-methyltransferase (COMT) genes, and paranoid and motor-impulsive symptoms in MAUD patients. A total of 189 MAUD patients participated in our study.
View Article and Find Full Text PDFAssociative gene networks reveal novel candidates important for ADHD and dyslexia comorbidity.
BMC Med Genomics
September 2023
Medical College of Shihezi University, Shihezi, China.
Background: Attention deficit hyperactivity disorder (ADHD) is commonly associated with developmental dyslexia (DD), which are both prevalent and complicated pediatric neurodevelopmental disorders that have a significant influence on children's learning and development. Clinically, the comorbidity incidence of DD and ADHD is between 25 and 48%. Children with DD and ADHD may have more severe cognitive deficiencies, a poorer level of schooling, and a higher risk of social and emotional management disorders.
View Article and Find Full Text PDFAnalysis of neurotransmitters validates the importance of the dopaminergic system in autism spectrum disorder.
World J Pediatr
August 2023
Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, 482 Madudah, Plot I-24, Sector-J, E.M. Bypass, Kolkata, West Bengal, 700107, India.
Article Synopsis
- The study explores the connection between autism spectrum disorder (ASD) and specific genetic variations of the dopamine receptor D4 (DRD4), highlighting its potential impact on communication deficits and repetitive behaviors associated with ASD.
- Researchers analyzed various DRD4 genetic polymorphisms and measured dopamine levels and mRNA expression, discovering that certain variants show a significant association with ASD symptoms and altered dopamine regulation.
- The findings indicate that individuals with ASD had lower levels of dopamine and norepinephrine, along with specific genetic variants correlated with these changes, suggesting a link between genetic makeup and socio-emotional challenges in people with ASD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!